FLUORO: Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy (clinicaltrials.gov) - Oct 17, 2026 - P2 | N=15 | Active, not recruiting | Sponsor: Olivia Newton-John Cancer Research Institute | Trial completion date: Jul 2025 ➔ Jul 2027
Trial completion date • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Oncology
|